Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Growth in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totaling 2,265 shares, an increase of 324.2% from the June 15th total of 534 shares. Based on an average daily volume of 7,256 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the company’s stock are short sold.

Fidelity Disruptive Medicine ETF Trading Down 0.0%

FMED stock traded down $0.01 during midday trading on Tuesday, hitting $29.06. 686 shares of the company’s stock were exchanged, compared to its average volume of 12,377. Fidelity Disruptive Medicine ETF has a 12-month low of $22.80 and a 12-month high of $30.33. The stock has a market capitalization of $46.50 million, a price-to-earnings ratio of 41.33 and a beta of 0.74. The firm has a 50 day moving average price of $26.13 and a 200-day moving average price of $26.00.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

Several hedge funds have recently made changes to their positions in the business. Glass Jacobson Investment Advisors llc grew its stake in Fidelity Disruptive Medicine ETF by 44.0% in the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after purchasing an additional 385 shares in the last quarter. Virtu Financial LLC bought a new position in Fidelity Disruptive Medicine ETF in the 4th quarter worth approximately $228,000. Vise Technologies Inc. bought a new position in shares of Fidelity Disruptive Medicine ETF in the 4th quarter worth $234,000. BXM Wealth LLC acquired a new stake in shares of Fidelity Disruptive Medicine ETF during the fourth quarter worth about $243,000. Finally, Jane Street Group LLC boosted its position in shares of Fidelity Disruptive Medicine ETF by 0.8% during the first quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock worth $1,567,000 after buying an additional 499 shares during the period.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.